M. Andrianifahanana, N. Moniaux, and S. K. Batra, Regulation of mucin expression: Mechanistic aspects and implications for cancer and inflammatory diseases, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1765, issue.2, pp.1765-189, 2006.
DOI : 10.1016/j.bbcan.2006.01.002

N. Jonckheere and I. Van-seuningen, The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers, Biochimie, vol.92, issue.1, pp.1-11, 2010.
DOI : 10.1016/j.biochi.2009.09.018

D. W. Kufe, Mucins in cancer: function, prognosis and therapy, Nature Reviews Cancer, vol.34, issue.12, pp.874-885, 2009.
DOI : 10.1038/nrc2761

A. Thor, N. Ohuchi, C. A. Szpak, W. W. Johnston, and J. Schlom, Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3, Cancer Research, vol.46, pp.3118-3124, 1986.

A. Thor, M. J. Viglione, R. Muraro, N. Ohuchi, J. Schlom et al., Monoclonal Antibody B72.3 Reactivity with Human Endometrium, International Journal of Gynecological Pathology, vol.6, issue.3, pp.235-247, 1987.
DOI : 10.1097/00004347-198709000-00005

M. Nuti, Y. A. Teramoto, R. Mariani-costantini, P. H. Hand, D. Colcher et al., A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations, International Journal of Cancer, vol.74, issue.5, pp.539-545, 1982.
DOI : 10.1002/ijc.2910290509

R. Muraro, M. Kuroki, D. Wunderlich, D. J. Poole, D. Colcher et al., Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen, Cancer Research, vol.48, pp.4588-4596, 1988.

J. Bell, C. Mojzisik, G. Hinkle, J. Derman, H. Schlom et al., Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe, International Journal of Gynecology & Obstetrics, vol.35, issue.3, pp.607-611, 1990.
DOI : 10.1016/0020-7292(91)90342-3

R. F. Meredith, A. J. Bueschen, M. B. Khazaeli, W. E. Plott, W. E. Grizzle et al., Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49, The Journal of Nuclear Medicine, vol.35, pp.1017-1022, 1994.

D. Colcher, D. E. Milenic, P. Ferroni, J. A. Carrasquillo, J. C. Reynolds et al., In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer, The Journal of Nuclear Medicine, vol.31, pp.1133-1142, 1990.

C. R. Divgi, A. M. Scott, L. Dantis, P. Capitelli, K. Siler et al., Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma, The Journal of Nuclear Medicine, vol.36, pp.586-592, 1995.

J. H. Xiang, J. Roder, and N. Hozumi, Production of murine V-human cr1 chimeric anti-tag72 antibody using V region cdna amplified by PCR, Molecular Immunology, vol.27, issue.8, pp.809-817, 1990.
DOI : 10.1016/0161-5890(90)90091-D

S. V. Kashmiri, L. Shu, E. A. Padlan, D. E. Milenic, J. Schlom et al., Studies of Humanized Anticarcinoma Antibody CC49, Hybridoma, vol.14, issue.5, pp.461-473, 1995.
DOI : 10.1089/hyb.1995.14.461

F. Rahbarizadeh, M. J. Rasaee, M. Forouzandeh, A. Allameh, R. Sarrami et al., The Production and Characterization of Novel Heavy-Chain Antibodies Against the Tandem Repeat Region of MUC1 Mucin, Immunological Investigations, vol.29, issue.5, pp.431-452, 2005.
DOI : 10.1021/bi991830w

D. Ahmadvand, M. J. Rasaee, F. Rahbarizadeh, R. E. Kontermann, and F. Sheikholislami, Cell selection and characterization of a novel human endothelial cell specific nanobody, Molecular Immunology, vol.46, issue.8-9, pp.1814-1823, 2009.
DOI : 10.1016/j.molimm.2009.01.021

M. M. Harmsen and H. J. De-haard, Properties, production, and applications of camelid single-domain antibody fragments, Applied Microbiology and Biotechnology, vol.77, issue.1, pp.13-22, 2007.
DOI : 10.1007/s00253-007-1142-2

T. Logtenberg, Antibody cocktails: next-generation biopharmaceuticals with improved potency, Trends in Biotechnology, vol.25, issue.9, pp.390-394, 2007.
DOI : 10.1016/j.tibtech.2007.07.005

J. Sharon, M. A. Liebman, and B. R. Williams, Recombinant polyclonal antibodies for cancer therapy, Journal of Cellular Biochemistry, vol.16, issue.2, pp.305-313, 2005.
DOI : 10.1002/jcb.20536

C. Newcombe and A. R. Newcombe, Antibody production: Polyclonal-derived biotherapeutics, Journal of Chromatography B, vol.848, issue.1, pp.2-7, 2007.
DOI : 10.1016/j.jchromb.2006.07.004

A. Ghahroudi, M. Desmyter, A. Wyns, L. Hamers, R. Muyldermans et al., Selection and identification of single domain antibody fragments from camel heavy-chain antibodies, FEBS Letters, vol.15, issue.3, pp.521-526, 1997.
DOI : 10.1016/S0014-5793(97)01062-4

H. R. Hoogenboom, J. T. Lutgerink, M. M. Pelsers, M. J. Rousch, J. Coote et al., Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library, European Journal of Biochemistry, vol.260, issue.3, pp.774-784, 1999.
DOI : 10.1046/j.1432-1327.1999.00214.x

N. Alvarez-rueda, G. Behar, V. Ferre, M. Pugniere, F. Roquet et al., Generation of llama single-domain antibodies against methotrexate, a prototypical hapten, Molecular Immunology, vol.44, issue.7, pp.1680-1690, 2007.
DOI : 10.1016/j.molimm.2006.08.007
URL : https://hal.archives-ouvertes.fr/hal-00258931

F. Rahbarizadeh, M. J. Rasaee, M. Forouzandeh, and A. A. Allameh, Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris, Molecular Immunology, vol.43, issue.5, pp.426-435, 2006.
DOI : 10.1016/j.molimm.2005.03.003

M. Dumoulin, K. Conrath, A. Van-meirhaeghe, F. Meersman, K. Heremans et al., Single-domain antibody fragments with high conformational stability, Protein Science, vol.377, issue.3, pp.500-515, 2002.
DOI : 10.1110/ps.34602

M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1038/227680a0

E. Engvall, [28] Enzyme immunoassay ELISA and EMIT, Methods in Enzymology, vol.70, pp.419-439, 1980.
DOI : 10.1016/S0076-6879(80)70067-8

A. Hombach, C. Heuser, R. Sircar, T. Tillmann, V. Diehl et al., T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope, Gastroenterology, vol.113, issue.4, pp.1163-1170, 1997.
DOI : 10.1053/gast.1997.v113.pm9322511

D. Saerens, B. Stijlemans, T. N. Baral, G. T. Nguyen-thi, U. Wernery et al., Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens, Journal of Immunological Methods, vol.329, issue.1-2, pp.138-150, 2008.
DOI : 10.1016/j.jim.2007.10.005

J. D. Beatty, B. G. Beatty, and W. G. Vlahos, Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay, Journal of Immunological Methods, vol.100, issue.1-2, pp.173-179, 1987.
DOI : 10.1016/0022-1759(87)90187-6

N. Domingo, J. Grosclaude, E. Bekaert, D. Mege, M. Chapman et al., Epitope mapping of the human biliary amphipathic, anionic polypeptide: Similarity with a calcium-binding protein isolated from gallstones and bile, and immunologic cross-reactivity with apolipoprotein AI, Journal of Lipid Research, vol.33, pp.1419-1430, 1992.

A. Beck, T. Wurch, C. Bailly, and N. Corvaia, Strategies and challenges for the next generation of therapeutic antibodies, Nature Reviews Immunology, vol.368, issue.5, pp.345-352, 2010.
DOI : 10.1038/nri2747

P. Holliger and P. J. Hudson, Engineered antibody fragments and the rise of single domains, Nature Biotechnology, vol.10, issue.9, pp.1126-1136, 2005.
DOI : 10.1182/blood-2005-03-1153

K. Coppieters, T. Dreier, K. Silence, H. De-haard, M. Lauwereys et al., Formatted anti???tumor necrosis factor ?? VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis, Arthritis & Rheumatism, vol.98, issue.6, pp.1856-1866, 2006.
DOI : 10.1002/art.21827

V. Cortez-retamozo, N. Backmann, P. D. Senter, U. Wernery, P. De-baetselier et al., Efficient Cancer Therapy with a Nanobody-Based Conjugate, Cancer Research, vol.64, issue.8, pp.2853-2857, 2004.
DOI : 10.1158/0008-5472.CAN-03-3935

R. Mutuberria, H. R. Hoogenboom, E. Van-der-linden, A. P. De-bruine, and R. C. Roovers, Model systems to study the parameters determining the success of phage antibody selections on complex antigens, Journal of Immunological Methods, vol.231, issue.1-2, pp.65-81, 1999.
DOI : 10.1016/S0022-1759(99)00141-6

N. Ohuchi, E. Gero, S. Mori, M. Akimoto, N. Matoba et al., Clinical evaluation of CA72-4 immunoradiometric assay for serum TAG-72 antigen in patients with carcinoma, Journal of Tumor Marker Oncology, vol.5, pp.1-10, 1990.

S. I. Rudnick and G. P. Adams, Affinity and Avidity in Antibody-Based Tumor Targeting, Cancer Biotherapy & Radiopharmaceuticals, vol.24, issue.2, pp.155-161, 2009.
DOI : 10.1089/cbr.2009.0627
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902227

M. Ouyang, W. Wu, Y. Zou, J. Zhou, Z. Wang et al., Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma, Surgical Oncology, vol.19, issue.2, pp.82-87, 2010.
DOI : 10.1016/j.suronc.2009.03.010

S. F. Slovin, H. I. Scher, C. R. Divgi, V. Reuter, G. Sgouros et al., Interferon-gamma and monoclonal antibody 131I-labeled CC49: Outcomes in patients with androgen-independent prostate cancer, Clinical Cancer Research, vol.4, pp.643-651, 1998.

P. H. Hand, D. Colcher, D. Salomon, J. Ridge, P. Noguchi et al., Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein, Cancer Research, vol.45, pp.833-840, 1985.

E. Sadeqzadeh, F. Rahbarizadeh, D. Ahmadvand, M. J. Rasaee, L. Parhamifar et al., Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells, Journal of Controlled Release, vol.156, issue.1, pp.85-91, 2011.
DOI : 10.1016/j.jconrel.2011.06.022

F. J. Iri-sofla, F. Rahbarizadeh, D. Ahmadvand, and M. J. Rasaee, Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase, Experimental Cell Research, vol.317, issue.18, pp.2630-2641, 2011.
DOI : 10.1016/j.yexcr.2011.08.015